Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient

References

• WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham StudyStroke19912289839881866765
   PubMed Web of Science ®Google Scholar
• WangTJMassaroJMLevyDA risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart StudyJAMA200329081049105612941677
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
   PubMed Web of Science ®Google Scholar
• BenjaminEJWolfPAD’AgostinoRBSilbershatzHKannelWBLevyDImpact of atrial fibrillation on the risk of death: the Framingham Heart StudyCirculation199898109469529737513
   PubMed Web of Science ®Google Scholar
• HannonNSheehanOKellyLStroke associated with atrial fibrillation–incidence and early outcomes in the north Dublin population stroke studyCerebrovasc Dis2010291434919893311
   PubMed Web of Science ®Google Scholar
• KannelWBWolfPABenjaminEJLevyDPrevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimatesAm J Cardiol1998828A2N9N
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEBaileyKRMortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based studyJ Am Coll Cardiol200749998699217336723
   PubMed Web of Science ®Google Scholar
• PenadoSCanoMAchaOHernándezJLRianchoJAAtrial fibrillation as a risk factor for stroke recurrenceAm J Med2003114320621012637135
   PubMed Web of Science ®Google Scholar
• StewartSHartCLHoleDJMcMurrayJJA population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyAm J Med2002113535936412401529
   PubMed Web of Science ®Google Scholar
• VidailletHGranadaJFChyouPHA population-based study of mortality among patients with atrial fibrillation or futterAm J Med2002113536537012401530
   PubMed Web of Science ®Google Scholar
• FitzmauriceDAHobbsFDRJowettSScreening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trialBMJ2007335761638317673732
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
   PubMed Web of Science ®Google Scholar
• LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillationChest2010137226327219762550
   PubMed Web of Science ®Google Scholar
• HoKKPinskyJLKannelWBLevyDThe epidemiology of heart failure: the Framingham StudyJ Am Coll Cardiol1993224 Suppl A6A13A8509564
   PubMed Web of Science ®Google Scholar
• National Center for Health StatisticsBlood Pressure Levels in Persons 18–74 Years of Age in 1976–1980 and Trends in Blood Pressure from 1960 to 1980 in the United States Vital and Health Statistics, series 11Washington DCUS Government Printing Office1986 DHHS publication 86-1684
   Google Scholar
• WilsonPWAndersonKMKannelWBEpidemiology of diabetes mellitus in the elderly. The Framingham StudyAm J Med1986805A393706388
   PubMed Web of Science ®Google Scholar
• SinnaevePRBrueckmannMClemensAOldgrenJEikelboomJHealeyJSStroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulationJ Intern Med20122711152421995885
   PubMed Web of Science ®Google Scholar
• AguilarMIHartROral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksCochrane Database Syst Rev20053CD00192716034869
   PubMed Web of Science ®Google Scholar
• van WalravenCHartRGConnollySEffect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigatorsStroke20094041410141619182090
   PubMed Web of Science ®Google Scholar
• HylekEMD’AntonioJEvans-MolinaCSheaCHenaultLEReganSTranslating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillationStroke20063741075108016527999
   PubMed Web of Science ®Google Scholar
• DeplanqueDLeysDParnettiLSAFE II InvestigatorsStroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II studyBr J Clin Pharmacol200457679880615151526
   PubMed Web of Science ®Google Scholar
• GoASHylekEMBorowskyLHPhillipsKASelbyJVSingerDEWarfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyAnn Intern Med19991311292793410610643
   PubMed Web of Science ®Google Scholar
• Allen LaPointeNMGovernaleLWatkinsJMulgundJAnstromKJOutpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillationAm Heart J2007154589389817967595
   PubMed Web of Science ®Google Scholar
• BrophyMTSnyderKEGaehdeSIvesCGagnonDFioreLDAnticoagulant use for atrial fibrillation in the elderlyJ Am Geriatr Soc20045271151115615209654
   PubMed Web of Science ®Google Scholar
• PartingtonSLAbidSTeoKOczkowskiWO’DonnellMJPreadmission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapyThromb Res2007120566366917434577
   PubMed Web of Science ®Google Scholar
• SavageMTeelingMBennettKFeelyJAdherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillationIr J Med Soc200617524649
   Google Scholar
• Bristol-Myers SquibbCoumadin^® (warfarin sodium) [prescribing information]New York, NYBristol-Myers Squibb2011 Available from: http://packageinserts.bms.com/pi/pi_coumadin.pdfAccessed August 8, 2012
   Google Scholar
• GattellariMWorthingtonJZwarNMiddletonSBarriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physiciansStroke200839122723018048861
   PubMed Web of Science ®Google Scholar
• ReynoldsMWFahrbachKHauchOWarfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysisChest200412661938194515596696
   PubMed Web of Science ®Google Scholar
• EsmerioFGSouzaENLeiriaTLLunelliRMoraesMAConstant use of oral anticoagulants: implications in the control of their adequate levelsArg Bras Cardiol2009935549554
   Web of Science ®Google Scholar
• ReynoldsMRShahJEssebagVPatterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL RegistryAm J Cardiol200697453854316461052
   PubMed Web of Science ®Google Scholar
• WanYHeneghanCPereraRAnticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic reviewCirc Cardiovasc Qual Outcomes200812849120031794
   PubMed Web of Science ®Google Scholar
• BakerWLCiosDASanderSDColemanCIMeta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United StatesJ Manag Care Pharm200915324425219326955
   PubMed Web of Science ®Google Scholar
• van WalravenCJenningsAOakeNFergussonDForsterAJEffect of study setting on anticoagulation control: a systematic review and metaregressionChest200612951155116616685005
   PubMed Web of Science ®Google Scholar
• MasakiNSuzukiMMatsumuraAMaruyamaYHashimotoYQuality of warfarin control affects the incidence of stroke in elderly patients with atrial fibrillationIntern Med201049161711171620720347
   PubMed Web of Science ®Google Scholar
• HobbsFDRoalfeAKLipGYFletcherKFitzmauriceDAMantJBirmingham Atrial Fibrillation in the Aged Investigators and Midland Research Practices Consortium NetworkPerformance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trialBMJ2011342d365321700651
   PubMed Web of Science ®Google Scholar
• RuttenFHHakEStalmanWAVerheijTJHoesAWIs treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?Fam Pract2003201162112509365
   PubMed Web of Science ®Google Scholar
• PistersRLaneDANieuwlaatRde VosCBCrijnsHJLipGYA novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart SurveyChest201013851093110020299623
   PubMed Web of Science ®Google Scholar
• GageBFYa nYMilliganPEClinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)Am Heart J2006151371371916504638
   PubMed Web of Science ®Google Scholar
• FangMCGoASChangYA new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyJ Am Coll Cardiol201158439540121757117
   PubMed Web of Science ®Google Scholar
• ApostolakisSLaneDAGuoYBullerHLipGYPerformance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) studyJ Am Coll Cardiol201260986186722858389
   PubMed Web of Science ®Google Scholar
• BondAJMolnarFJLiMMackeyMMan-Son-HingMThe risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapyThromb J200531115638939
   PubMedGoogle Scholar
• Man-Son-HingMLaupacisAAnticoagulant-related bleeding in older persons with atrial fibrillation: physicians’ fears often unfoundedArch Intern Med2003163131580158612860581
   PubMed Web of Science ®Google Scholar
• Man-Son-HingMNicholGLauALaupacisAChoosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for fallsArch Intern Med1999159767768510218746
   PubMedGoogle Scholar
• KhreizatHSWhittakerPCurtisKDTurloGGarwoodCLThe effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapyDrugs Aging201229430731722462629
   PubMed Web of Science ®Google Scholar
• FihnSDCallahanCMMartinDCMcDonellMBHenikoffJGWhiteRHThe risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation ClinicsAnn Intern Med1996124119709798624064
   PubMed Web of Science ®Google Scholar
• Authors/Task Force MembersCammAJLipGY2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
   PubMedGoogle Scholar
• FusterVRydénLECannomDS2011 ACCF/AHA/HRS focused updated incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyCirculation201112310e269e36721382897
   PubMed Web of Science ®Google Scholar
• YouJJSingerDEHowardPAAmerican College of Chest PhysiciansAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e531Se575S22315271
   PubMed Web of Science ®Google Scholar
• SatoHIshikawaKKitabatakeAJapan Atrial Fibrillation Stroke Trial GroupLow-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke TrialStroke200637244745116385088
   PubMed Web of Science ®Google Scholar
• OlesenJBLipGYLindhardsenJRisks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort studyThromb Haemost2011106473974921789337
   PubMed Web of Science ®Google Scholar
• MantJHobbsFDRFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
   PubMed Web of Science ®Google Scholar
• RashADownesTPortnerRYeoWWMorganNChannerKSA randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)Age Ageing200736215115617175564
   PubMed Web of Science ®Google Scholar
• Boehringer IngelheimPradaxa^® (dabigatran etexilate mesylate) [prescribing information]Ridgefeld, CTBoehringer Ingelheim2012 Available from: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdfAccessed February 25, 2013
   Google Scholar
• Bayer PharmaXarelto^® (rivaroxaban) [prescribing information]LeverkusenBayer Pharma2011 Available from: http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf#zoom=100Accessed February 25, 2013
   Google Scholar
• Bristol-Myers SquibbEliquis^® (apixaban) [prescribing information]Princeton, NJBristol-Myers Squibb2012 Available from: http://packageinserts.bms.com/pi/pi_eliquis.pdfAccessed January 4, 2013
   Google Scholar
• RuffCTBraunwaldEWill warfarin ever be replaced?J Cardiovasc Pharmacol Ther201015321021920484119
   PubMed Web of Science ®Google Scholar
• GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJAmerican College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis PanelExecutive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121417S47S22315257
   PubMed Web of Science ®Google Scholar
• WannLSCurtisABEllenbogenKA2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesJ Am Coll Cardiol201157111330133721324629
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSReillyPAWallentinLRandomized Evaluation of Long-Term Anticoagulation Therapy InvestigatorsNewly identified events in the RE-LY trialN Engl J Med2010363191875187621047252
   PubMed Web of Science ®Google Scholar
• EikelboomJWWallentinLConnollySJRisk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialCirculation2011123212363237221576658
   PubMed Web of Science ®Google Scholar
• UchinoKHernandezAVDabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trialsArch Intern Med2012172539740222231617
   PubMed Web of Science ®Google Scholar
• HohnloserSHOldgrenJYangSMyocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trialCirculation2012125566967622215856
   PubMed Web of Science ®Google Scholar
• BeasleyBNUngerEFTempleRAnticoagulant options–why the FDA approved a higher but not a lower dose of dabigatranN Engl J Med2011364191788179021488759
   PubMed Web of Science ®Google Scholar
• PatelMRMahaffeyKWGargJROCKET AF InvestigatorsRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med20113651088389121830957
   PubMed Web of Science ®Google Scholar
• HalperinJLWojdylaDPicciniJPEfficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular AF in the ROCKET-AF trialStroke201243A148
   Google Scholar
• GrangerCBAlexanderJHMcMurrayJJARISTOTLE Committees and InvestigatorsApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
   PubMed Web of Science ®Google Scholar
• LopesRDAl-KhatibSMWallentinLefficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialLancet201238098551749175823036896
   PubMed Web of Science ®Google Scholar
• ConnollySJEikelboomJJoynerCAVERROES Steering Committee and InvestigatorsApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
   PubMed Web of Science ®Google Scholar
• GurwitzJHFieldTSHarroldLRIncidence and preventability of adverse drug events among older persons in the ambulatory settingJAMA200328991107111612622580
   PubMed Web of Science ®Google Scholar
• Boehringer Ingelheim LimitedPradaxa^® (Dabigatran) [summary of product characteristics]Electronic Medicines Compendiumupdated 9212012 Available from: http://www.medicines.org.uk/EMC/medicine/24839/SPC/Pradaxa+150+mg+hard+capsules/Accessed January 3, 2013
   Google Scholar
• Bristol-Myers Squibb–PfizerEliquis^® (Apixaban) [summary of product characteristics]Electronic Medicines Compendiumupdated 3122012 Available from: http://www.medicines.org.uk/EMC/medicine/24988/SPC/Eliquis+2.5+mg+film-coated+tablets/Accessed February 3, 2012
   Google Scholar
• ParikhVChainaniVHowardMIs dabigatran safe in “real life”?J Am Coll Cardiol20125913s1E602
   Google Scholar
• RajdevABradleyJPetriniJAlexanderJA community experience of the novel anticoagulant PradaxaJ Am Coll Cardiol20125913s1E601
   Google Scholar
• SkanesACHealeyJSCairnsJACanadian Cardiovascular Society Atrial Fibrillation Guidelines CommitteeFocused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm controlCan J Cardiol201228212513622433576
   PubMed Web of Science ®Google Scholar
• KimmelSEChenZPriceMThe influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyArch Intern Med2007167322923517296877
   PubMed Web of Science ®Google Scholar
• LegrandMMateoJAribaudAThe use of dabigatran in elderly patientsArch Intern Med2011171141285128621788545
   PubMed Web of Science ®Google Scholar
• [Deaths of 15 patients as a side effect five months after commercial release: interim report survey]National Purazakisa2011928 Available from: http://www.mixonline.jp/tabid/55/artid/41434/Default.aspxAccessed January 31, 2013Japanese
   Google Scholar
• ErikssonBIQuinlanDJEikelboomJWNovel oral factor Xa and thrombin inhibitors in the management of thromboembolismAnnu Rev Med201162415721226611
   PubMed Web of Science ®Google Scholar
• HohnloserSHHijaziZThomasLefficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialEur Heart J201233222821283022933567
   PubMed Web of Science ®Google Scholar
• KamelHJohnstonSCEastonJDKimASCost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attackStroke201243388188322308255
   PubMed Web of Science ®Google Scholar
• ShahSVGageBFCost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillationCirculation2011123222562257021606397
   PubMed Web of Science ®Google Scholar
• FreemanJVZhuRPOwensDKCost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillationAnn Intern Med2011154111121041570
   PubMed Web of Science ®Google Scholar
• LeeSAngladeMWPhamDPisacaneRKlugerJColemanCICosteffectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillationAm J Cardiol2012110684585122651881
   PubMed Web of Science ®Google Scholar
• KamelHEastonJDJohnstonSCKimASCost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillationNeurology201279141428143422993279
   PubMed Web of Science ®Google Scholar
• LeeSAngladeMWMengJHagstromKKlugerJColemanCICost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarinCirc Cardiovasc Qual Outcomes20125447247922740012
   PubMed Web of Science ®Google Scholar
• DeitelzweigSAminAJingYMedical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trialsJ Med Econ201215477678522449118
   PubMedGoogle Scholar
• De CaterinaRHustedSWallentinLCoordinating CommitteeNew oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paperJ Am Coll Cardiol201259161413142522497820
   PubMed Web of Science ®Google Scholar
• EerenbergESKamphuisenPWSijpkensMKMeijersJCBullerHRLeviMReversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjectsCirculation2011124141573157921900088
   PubMed Web of Science ®Google Scholar
• EscolarGArellano-RodrigoEReverterJCReversal of apixaban induced alterations of hemostasis by different coagulation factor concentrates: studies in vitro with circulating human bloodCirculation20121264520521
   Google Scholar
• BarillariGPascaSBarillariADe AngelisVEmergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experienceBlood Transfus2012101879422044952
   PubMed Web of Science ®Google Scholar
• BruceDNokesTJProthrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospitalCrit Care2008124R10518706082
   PubMed Web of Science ®Google Scholar
• WolfPAAbbottRDKannelWBAtrial fibrillation: a major contributor to stroke in the elderly. The Framingham StudyArch Intern Med19871479156115643632164
   PubMedGoogle Scholar